UEGW2008 2008年10月25日 09時23分21秒 | クローン病情報 UEGW2008(欧州消化器病週間)よりクローン病関連のニュースをピックアップ Natalizumab Reduces Hospitalisation Rates in Patients With Crohn's Disease: Presented at UEGW (DG News) Certolizumab Pegol Induces Mucosal Healing and Clinical Remission in Crohn's Disease: Presented at UEGW (DG News) Certolizumab Pegol Effective in Patients With Crohn's Disease Who Have Failed Infliximab Therapy: Presented at UEGW (DG News) No Benefit to Methotrexate Induction and Maintenance Therapy in Crohn's Disease: Presented at UEGW (DG News) Flexible Dosing of Infliximab Ensures Long-Term Response in Crohn's Disease: Presented at UEGW (DG News) Long-Term Therapy With Infliximab Proves Effective and Safe in Inflammatory Bowel Disease: Presented at UEGW (DG News) « ある特定の細菌の不足が腸の... | トップ | 気になるメモ »